olopatadine mometasone nasal Ryaltris
Selected indexed studies
- Allergic Rhinitis: A Review. (JAMA, 2024) [PMID:38470381]
- ** (, 2025) [PMID:40424422]
- ** (, 2025) [PMID:40857372]
_Worker-drafted node — pending editorial review._
Connections
olopatadine mometasone nasal Ryaltris is a side effect of
Sources
- Allergic Rhinitis: A Review. (2024) pubmed
- PMID:40857372 (2025) pubmed
- PMID:40424422 (2025) pubmed
- Efficacy and safety of twice-daily olopatadine-mometasone combination nasal spray (GSP301) in the treatment of allergic rhinitis: a systematic review and meta-analysis. (2022) pubmed
- Olopatadine-mometasone combination nasal spray: Evaluation of efficacy and safety in patients with seasonal allergic rhinitis. (2019) pubmed
- Efficacy and safety of olopatadine-mometasone combination nasal spray for the treatment of seasonal allergic rhinitis. (2019) pubmed
- Effect of olopatadine-mometasone combination nasal spray on seasonal allergic rhinitis symptoms in an environmental exposure chamber study. (2019) pubmed
- Efficacy and safety of olopatadine-mometasone combination nasal spray for the treatment of seasonal allergic rhinitis. (2026) pubmed
- Patient Satisfaction and Sensory Attributes of Nasal Spray Treatments of Olopatadine Hydrochloride/Mometasone Furoate Monohydrate and Azelastine Hydrochloride/Fluticasone Propionate for Allergic Rhinitis in Australia - An Observational Real-World Clinical Study. (2023) pubmed
- Intranasal Olopatadine-Mometasone in the Treatment of Seasonal Allergic Rhinitis. (2023) pubmed